volume 54, issue 3, P291-300 2009
DOI: 10.1111/j.1755-3768.1976.tb01258.x
View full text
|
|
Share
ANDERS BORTHNE

Abstract: The effect of propranolol (Inderal) on the intraocular pressure (IOP) in glaucoma has been measured. Twenty-two patients completed the clinical trial. Propranolol in doses of 160 mg/d effectively lowered IOP in eyes with various types of open angle glaucoma. The test periods lasted from 4 to 6 days. The ocular hypotensive effect of propranolol was also registered in patients efficiently treated with pilocarpine and acetazolamide (Diamox), and in glaucomas not satisfactorily controlled by this therapy. High pos…

expand abstract